Developing and Marketing an FDA-Regulated Test
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read MorePosted by Elaine Sanchez Wilson | Feb 9, 2016 | Cancer, Microbiology Instruments, Molecular Diagnostics |
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read MorePosted by Elaine Sanchez Wilson | Jan 25, 2016 | Cancer, Molecular Diagnostics |
The GeneStrat noninvasive, blood-based test is designed to provide accurate results in 72 hours for newly diagnosed non-small cell lung cancer patients.
Read MorePosted by Elaine Sanchez Wilson | Jan 19, 2016 | Cancer, Unknown Origin & Other Cancer Types |
In this month’s Inside Track, Nadia Altomare, CEO of Abcodia, discusses how her company’s test can lead to improved clinical outcomes.
Read MorePosted by Elaine Sanchez Wilson | Jan 7, 2016 | Disease States |
In recent years, populations in a number of regions throughout the world have found themselves at ground zero for an increasing variety of previously unknown infectious and zoonotic diseases.
Read MorePosted by Elaine Sanchez Wilson | Dec 22, 2015 | Cancer, Microbiology Instruments |
Featured emerging technologies include a portable DNA sequencing tool, a BICD2 protein marker, a blood culture assay kit, and a handheld DNA amplification system.
Read More